Tempus, a Chicago-based health technology company, wants oncologists to talk to the cube.
The cube, in this case, is a device called Tempus One that doctors will be able to put in their lab coat pockets and bring with them as they round at hospitals, asking questions about their patients, the genetic data of tumors, and the availability of clinical trials. Think of it as a tumor science version of Amazon’s Alexa.
Tempus One is being unveiled at the company’s presentation at the J.P. Morgan Healthcare Conference Monday. Tempus is privately held, and has raised more than $1 billion from venture investors. As of December, Pitchbook puts the company’s valuation at $8.1 billion. The big question, unanswerable without more data: will the dramatic-looking gadget add much to patient care?